Nattokinase SHRANK arterial plaque by 36% with ZERO adverse effects.
The study found 95.4% of patients taking 10,800 FU daily for 12 months experienced some degree of cardiovascular improvement.
The 36% plaque reduction was verified using carotid artery ultrasound.